Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 368121 - 368140 out of 498614 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Romania (legislatie) | (L01FF03) durvalumab | IMFINZI 50 mg/ml | Cutie cu 1 flac. din sticla a 10 ml conc. (care conține 500 mg durvalumab) (3 ani),CONC. PT. SOL. PERF., 50mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ASTRAZENECAAB-SUEDIA |
| Romania (legislatie) | (L01FF04) avelumab | BAVENCIO 20 mg/ml | 1 flacon x 10 ml conc. pt. sol. perf. (200 mg avelumab) (2 ani),CONC. PT. SOL. PERF., 20 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | MERCKEUROPEB.V.-OLANDA |
| Romania (legislatie) | (L01FF05) atezolizumab | TECENTRIQ 1200mg | Cutie cu 1 flac. din sticla x 20 ml conc. pt.sol. perf. (3 ani),CONC.PT. SOL. PERF., 1200mg/20ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH-GERMANIA |
| Romania (legislatie) | (L01FF05) atezolizumab | TECENTRIQ 1875 mg | Cutie cu 1 flac. din sticla x 15 ml sol.inj. (2 ani),SOL. INJ., 1875mg/15ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | ROCHEREGISTRATIONGMBH-GERMANIA |
| Romania (legislatie) | (L01FF06) cemiplimab | LIBTAYO 350 mg | Cutie cu 1 flac. din sticla prevazuta cu dop din cauciuc cu strat FluroTec si un capac etans cu capsa detasabila x7ml conc. pt. sol. perf. (350 mg cemiplimab) (30 luni; Dupa prima deschidere - a se utiliza imediat),CONC.PT. SOL. PERF., 50 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | REGENERONIRELANDDAC-IRLANDA |
| Romania (legislatie) | (L01FF12) serplulimab | HETRONIFLY 10 mg/ml | Cutie cu 1flac.dinsticla transparenta de 10 ml contine 100 mg serplulimab (3 ani-flacon nedeschis),CONC. PT. SOL. PERF., 10mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Small Cell Lung Carcinoma | ACCORDHEALTHCARES.L.U.-SPANIA |
| Romania (legislatie) | (L01FG01) bevacizumab | ABEVMY 25 mg/ml | Cutie cu 1 flac. a 4 ml conc. pt. sol. perf. care conține 100 mg bevacizumab (30 luni - flac. nedeschis),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED-IRLANDA |
| Romania (legislatie) | (L01FG01) bevacizumab | ABEVMY 25 mg/ml | Cutie cu 1 flac. a 16 ml conc. pt. sol. perf. care conține 400 mg de bevacizumab (30 luni - flac. nedeschis),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | BIOSIMILARCOLLABORATIONSIRELANDLIMITED-IRLANDA |
| Romania (legislatie) | (L01FG01) bevacizumab | ALYMSYS 25 mg/ml | Cutie cu 1 flac. a 4 ml sol. care conține 100 mg bevacizumab,CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL |
| Romania (legislatie) | (L01FG01) bevacizumab | ALYMSYS 25 mg/ml | Cutie cu 1 flac. a 16 ml sol. care conține400 mg bevacizumab,CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | MABXIENCERESEARCHSL |
| Romania (legislatie) | (L01FG01) bevacizumab | AVASTIN 25 mg/ml | Cutie x 1 flac. din sticla x4 ml conc. pt. sol. perf.,CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FG01) bevacizumab | AVASTIN 25 mg/ml | Cutie x 1 flac. din sticla x 16 ml conc. pt. sol. perf.,CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Uterine Cervical Neoplasms | ROCHEREGISTRATIONGMBH |
| Romania (legislatie) | (L01FG01) bevacizumab | MVASI 25 mg/ml | Cutie x1flac. din sticlax4 ml conc. pt. sol. perf.(100 mg bevacizumab),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGY(IRELAND)UC |
| Romania (legislatie) | (L01FG01) bevacizumab | MVASI 25 mg/ml | Cutie x 1 flac. din sticla x 16 ml conc. pt. sol. perf.(400 mg bevacizumab),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AMGENTECHNOLOGY(IRELAND)UC |
| Romania (legislatie) | (L01FG01) bevacizumab | OYAVAS 25 mg/ml | Cutie cu un flacon x 16ml concentrat pentru soluție perfuzabila (conține400 mg bevacizumab),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG |
| Romania (legislatie) | (L01FG01) bevacizumab | OYAVAS 25 mg/ml | Cutie cu un flacon x4ml concentrat pentru soluție perfuzabila (conține 100 mg bevacizumab),CONC. PT. SOL. PERF., 25 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | STADAARZNEIMITTELAG |
| Romania (legislatie) | (L01FG01) bevacizumab | VEGZELMA25 mg/ml | Cutie cu 1 flac. a 4 ml care contine 100 mg de bevacizumab (2 ani),CONC.PT. SOL. PERF., 25mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.-UNGARIA |
| Romania (legislatie) | (L01FG01) bevacizumab | VEGZELMA25 mg/ml | Cutie cu 1 flac. a 16 ml care contine400 mg de bevacizumab (4 ani),CONC.PT. SOL. PERF., 25mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CELLTRIONHEALTHCAREHUNGARYKFT.-UNGARIA |
| Romania (legislatie) | (L01FG01) bevacizumab | ZIRABEV 25mg/ml | Cutie x1flac. din sticlax4 ml conc. pt. sol. perf.(100mg bevacizumab),CONC.PT. SOL. PERF., 25mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG |
| Romania (legislatie) | (L01FG01) bevacizumab | ZIRABEV 25mg/ml | Cutie x 1 flac. din sticla x 16 ml conc. pt. sol. perf.(400mg bevacizumab),CONC.PT. SOL. PERF., 25mg/ml | Retail price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | PFIZEREUROPEMAEEIG |
Pages
